Thermo Fisher Scientific, The World Leader In Serving Science, Today Announced The Launch Of Its Applied Biosystems Hiv-1 Genotyping Kit With Integrase, A Research Use Only Assay That Examines Positive Samples Of Human Immunodeficiency Virus (Hiv) To Identify Genetic Variants That Resist Common Antiretrovial Therapeutics.Hiv Rna Extracted From Edta Plasma Or Dried Blood Spots Is Analyzed With The Assay To Measure Genomic Mutations In The Protease, Reverse Transcriptase And Integrase Regions Of The Pol Gene. Data From These Tests Is Intended To Help Inform Global Epidemiologic And Genetic Surveillance Studies To Track The Ongoing Evolution Of The Virus.The Kit Is Designed To Support The Detection Of The Unaids 2030 95-95-95 Hiv Targets, Which Aims To Have 95 Percent Of People Living With Hiv To Be Diagnosed, 95 Percent Who Are Diagnosed To Be Receiving Treatment, And 95 Percent Of Those On Treatment To Be Virally Suppressed. This Enhanced Research Assay, Which Is Compatible With The Recently Launched Applied Biosystems Magmax Viral/Pathogen Nucleic Acid Isolation Kit For Hiv-1 Blood Spots, Provides Laboratories With A Standardized Tool For Drug Resistance Surveillance Of Hiv Mutations To Antiretroviral Therapeutic Inhibitors Which Can Help Identify Global Areas Of Need.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!